GTBP
:GT Biopharma Inc *
Snapshot
|
Charting
|
News
|
Options
*
Deficient
:
Issuer Failed to Meet NASDAQ Continued Listing Requirements
$8.61
39.32%
$2.43
NASDAQ
8:00a ET
August 14 '26
GT Biopharma Reports Second Quarter 2026 Financial Results
GlobeNewswire
Last
Change
Exchange
Market data is delayed by at least 15 minutes.
Markets
Portfolio
Symbol Lookup
Show me
Calls
Puts
Both
Options that expire in
Show All
No Options for GTBP
Market data provided by
News provided by